{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T02:27:03Z","timestamp":1783823223595,"version":"3.55.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T00:00:00Z","timestamp":1533254400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2018.00434","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T04:31:38Z","timestamp":1533270698000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Glycometabolic Alterations in Secondary Adrenal Insufficiency: Does Replacement Therapy Play a Role?"],"prefix":"10.3389","volume":"9","author":[{"given":"Chiara","family":"Graziadio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Hasenmajer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Venneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Gianfrilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Isidori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Sbardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/S0140-6736(13)61684-0","article-title":"Adrenal insufficiency","volume":"383","author":"Charmandari","year":"2014","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1210\/er.2009-0033","article-title":"Mortality in patients with pituitary disease","volume":"31","author":"Sherlock","year":"2010","journal-title":"Endocr Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.23736\/S0391-1977.17.02701-8","article-title":"Secondary adrenal insufficiency: from the physiopathology to the possible role of modified-release hydrocortisone treatment","volume":"43","author":"Paragliola","year":"2017","journal-title":"Minerva Endocrinol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/B978-0-444-59602-4.00026-5","article-title":"Uncertainties in endocrine substitution therapy for central hypocortisolism","volume":"124","author":"Swords","year":"2014","journal-title":"Handb Clin Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1210\/jc.2014-3191","article-title":"High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study","volume":"100","author":"Hahner","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"B6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"B7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1530\/EJE-08-0880","article-title":"Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone","volume":"160","author":"Lovas","year":"2009","journal-title":"Eur J Endocrinol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1530\/EJE-08-0578","article-title":"Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens","volume":"159","author":"Bleicken","year":"2008","journal-title":"Eur J Endocrinol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1210\/er.2015-1080","article-title":"The functional and clinical significance of the 24-hour rhythm of circulating glucocorticoids","volume":"38","author":"Oster","year":"2017","journal-title":"Endocr Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"R49","DOI":"10.1530\/JOE-14-0373","article-title":"Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes","volume":"223","author":"Rafacho","year":"2014","journal-title":"J Endocrinol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s00125-010-1684-1","article-title":"Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009","volume":"53","author":"DeFronzo","year":"2010","journal-title":"Diabetologia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"R231","DOI":"10.1530\/EJE-17-0154","article-title":"management of endocrine disease: risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects","volume":"177","author":"Mazziotti","year":"2017","journal-title":"Eur J Endocrinol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/S0140-6736(07)60673-4","article-title":"Hypopituitarism","volume":"369","author":"Schneider","year":"2007","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/509","article-title":"Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans","volume":"19","author":"Krude","year":"1998","journal-title":"Nat Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1210\/jc.2008-2380","article-title":"Modified-release hydrocortisone to provide circadian cortisol profiles","volume":"94","author":"Debono","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"B16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1530\/EJE-09-0170","article-title":"Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study","volume":"161","author":"Johannsson","year":"2009","journal-title":"Eur J Endocrinol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1210\/jc.2011-1926","article-title":"Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation","volume":"97","author":"Johannsson","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"B18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1530\/EJE-14-1114","article-title":"Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency","volume":"172","author":"Quinkler","year":"2015","journal-title":"Eur J Endocrinol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","article-title":"Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial","volume":"6","author":"Isidori","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/dme.12184","article-title":"Influence of glucocorticoids and growth hormone on insulin sensitivity in humans","volume":"30","author":"Yuen","year":"2013","journal-title":"Diabet Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/j.1365-2265.2012.04439.x","article-title":"BClI polymorphism of the glucocorticoid receptor gene is associated with increased obesity, impaired glucose metabolism and dyslipidaemia in patients with Addison's disease","volume":"77","author":"Giordano","year":"2012","journal-title":"Clin Endocrinol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1210\/er.2012-1050","article-title":"11beta-Hydroxysteroid dehydrogenase 1: translational and therapeutic aspects","volume":"34","author":"Gathercole","year":"2013","journal-title":"Endocr Rev."},{"key":"B23","first-page":"259","article-title":"Risk factors for steroid diabetes in rheumatic patients","volume":"29","author":"Raul","year":"1998","journal-title":"Arch Med Res."},{"key":"B24","first-page":"E592","article-title":"Dexamethasone-induced insulin resistance enhances B cell responsiveness to glucose level in normal men","volume":"247","author":"Beard","year":"1984","journal-title":"Am J Physiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/oby.2003.90","article-title":"Metabolic adaptations to dexamethasone-induced insulin resistance in healthy volunteers","volume":"11","author":"Nicod","year":"2003","journal-title":"Obes Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s00125-008-0995-y","article-title":"Evidence that autonomic mechanisms contribute to the adaptive increase in insulin secretion during dexamethasone-induced insulin resistance in humans","volume":"51","author":"Ahren","year":"2008","journal-title":"Diabetologia"},{"key":"B27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/MPA.0b013e31815ba826","article-title":"Functional alterations in endocrine pancreas of rats with different degrees of dexamethasone-induced insulin resistance","volume":"36","author":"Rafacho","year":"2008","journal-title":"Pancreas"},{"key":"B28","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1007\/s001250051251","article-title":"Insulin resistant subjects lack islet adaptation to short-term dexamethasone-induced reduction in insulin sensitivity","volume":"42","author":"Larsson","year":"1999","journal-title":"Diabetologia"},{"key":"B29","doi-asserted-by":"publisher","first-page":"6035","DOI":"10.1073\/pnas.89.13.6035","article-title":"The diabetogenic effects of glucocorticoids are more pronounced in low- than in high-insulin responders","volume":"89","author":"Wajngot","year":"1992","journal-title":"Proc Natl Acad Sci USA."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1007\/s00125-012-2459-7","article-title":"Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes","volume":"55","author":"Jensen","year":"2012","journal-title":"Diabetologia"},{"key":"B31","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/oby.2005.41","article-title":"Changes in insulin secretion and glucose metabolism induced by dexamethasone in lean and obese females","volume":"13","author":"Besse","year":"2005","journal-title":"Obes Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1677\/joe.0.1620425","article-title":"Insufficient adaptive capability of pancreatic endocrine function in dexamethasone-treated ageing rats","volume":"162","author":"Novelli","year":"1999","journal-title":"J Endocrinol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.2337\/diab.45.8.1094","article-title":"Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and beta-cell dysfunction","volume":"45","author":"Couce","year":"1996","journal-title":"Diabetes"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1677\/JOE-08-0290","article-title":"Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes","volume":"199","author":"Quesada","year":"2008","journal-title":"J Endocrinol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.1210\/jc.2010-0982","article-title":"Clinical Review#: the diagnosis and management of central hypoadrenalism","volume":"95","author":"Grossman","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1210\/jc.2014-2476","article-title":"Central hypoadrenalism","volume":"99","author":"Crowley","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"B37","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/cen.13267","article-title":"Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR","volume":"86","author":"Murray","year":"2017","journal-title":"Clin Endocrinol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/S0140-6736(16)30053-8","article-title":"Hypopituitarism","volume":"388","author":"Higham","year":"2016","journal-title":"Lancet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EC-16-0081","article-title":"Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency","volume":"6","author":"Quinkler","year":"2017","journal-title":"Endocr Connect."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1210\/jc.2006-0524","article-title":"The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients","volume":"91","author":"Filipsson","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"B41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1210\/jcem-72-1-39","article-title":"Daily cortisol production rate in man determined by stable isotope dilution\/mass spectrometry","volume":"72","author":"Esteban","year":"1991","journal-title":"J Clin Endocrinol Metab."},{"key":"B42","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s12020-012-9835-4","article-title":"Therapy of adrenal insufficiency: an update","volume":"43","author":"Falorni","year":"2013","journal-title":"Endocrine"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1210\/jc.2013-4305","article-title":"Acute effect of increasing glucocorticoid replacement dose on cardiovascular risk and insulin sensitivity in patients with adrenocorticotrophin deficiency","volume":"99","author":"Petersons","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"B44","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1365-2265.1995.tb02928.x","article-title":"Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism","volume":"43","author":"Dunne","year":"1995","journal-title":"Clin Endocrinol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11102-008-0126-2","article-title":"Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study","volume":"11","author":"Danilowicz","year":"2008","journal-title":"Pituitary"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ando.2014.11.004","article-title":"An observational study on adrenal insufficiency in a French tertiary centre: Real life versus theory","volume":"76","author":"Castinetti","year":"2015","journal-title":"Ann Endocrinol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1365-2265.2009.03596.x","article-title":"Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency","volume":"72","author":"Bleicken","year":"2010","journal-title":"Clin Endocrinol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"E1938","DOI":"10.1210\/jc.2012-2432","article-title":"Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma","volume":"97","author":"Zueger","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"B49","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1530\/EJE-12-0351","article-title":"Effects of standard glucocorticoid replacement therapies on subjective well-being: a randomized, double-blind, crossover study in patients with secondary adrenal insufficiency","volume":"167","author":"Benson","year":"2012","journal-title":"Eur J Endocrinol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1365-2265.2012.04352.x","article-title":"A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency","volume":"77","author":"Ekman","year":"2012","journal-title":"Clin Endocrinol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/cen.12865","article-title":"Incidence of adrenal crisis in patients with adrenal insufficiency","volume":"84","author":"Smans","year":"2016","journal-title":"Clin Endocrinol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1046\/j.0300-0664.2001.01447.x","article-title":"Effects of low-dose oral hydrocortisone replacement versus short-term reproduction of physiological serum cortisol concentrations on insulin action in adult-onset hypopituitarism","volume":"56","author":"McConnell","year":"2002","journal-title":"Clin Endocrinol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s12020-015-0681-z","article-title":"Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease","volume":"51","author":"Giordano","year":"2016","journal-title":"Endocrine"},{"key":"B54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1530\/EC-17-0368","article-title":"Dual-release hydrocortisone treatment: glycometabolic profile and health-related quality of life","volume":"7","author":"Mongioi","year":"2018","journal-title":"Endocr Connect."},{"key":"B55","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1210\/jc.84.9.3082","article-title":"Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning","volume":"84","author":"Plat","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"B56","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/cen.13554","article-title":"Improved insulin sensitivity and secretion in prediabetic patients with adrenal insufficiency on dual-release hydrocortisone treatment: a 36-month retrospective analysis","volume":"88","author":"Guarnotta","year":"2018","journal-title":"Clin Endocrinol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000360556","article-title":"Cardiovascular and metabolic impact of glucocorticoid replacement therapy","volume":"43","author":"Johannsson","year":"2014","journal-title":"Front Horm Res."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00346","article-title":"Circadian rhythm of glucocorticoid administration entrains clock genes in immune cells: a DREAM trial ancillary study","author":"Venneri","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"key":"B59","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1365-2796.2007.01766.x","article-title":"Effects of rotating shift work on biomarkers of metabolic syndrome and inflammation","volume":"261","author":"Sookoian","year":"2007","journal-title":"J Intern Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1183\/09031936.00138207","article-title":"Clock gene dysfunction in patients with obstructive sleep apnoea syndrome","volume":"32","author":"Burioka","year":"2008","journal-title":"Eur Respir J."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00434\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T04:31:42Z","timestamp":1533270702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00434\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,3]]},"references-count":60,"alternative-id":["10.3389\/fendo.2018.00434"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2018.00434","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,3]]},"article-number":"434"}}